-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AS-1763 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AS-1763 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AS-1763 in Marginal Zone B-cell Lymphoma Drug Details: AS-1763...
-
Analyst Opinions
North America Energy Transition by Key Sectors and Companies Driving Development
North America Energy Transition Market Report Overview North America’s energy transition is continuing to gather pace, with a combination of technological development and favourable policy incentives driving substantial growth across renewables, hydrogen, and CCUS sectors. Technologies such as electric vehicles and renewable fuels are also experiencing increasing adoption albeit at a slower rate. The ‘North America Energy Transition’ market research report provides analysis and trends on North America’s energy transition from non-renewable to renewable sources. Key Power Types ·      Coal...
-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
Ultrasound Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ultrasound Systems Pipeline Market Report Overview Ultrasound Systems are devices that make use of sound waves of high frequency to produce images of structures inside the body. Most of the devices use Sonar principles and are placed outside while in a few cases, they are even placed inside of the body. 2D Ultrasound Systems, 3D Ultrasound Systems, Real-Time 3D Ultrasound Systems, and Hand Held Ultrasound (HHU) Systems are tracked under this category. The Ultrasound Systems pipeline market research report provides...
-
Product Insights
Reproductive Health Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Reproductive Health Devices Pipeline Market Report Overview Endometrial ablation devices, female sterilization devices, reversible contraceptive devices, and assisted reproductive technology devices are the main categories of reproductive health devices. The reproductive health devices pipeline report provides comprehensive information about the main products with their comparative segment-wise analysis at various stages of development. The following are some of the key highlights of the reproductive health devices pipeline market: As of February 2024, the reversible contraceptive devices segment was the leading segment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EV-PURE in Premature Ovarian Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EV-PURE in Premature Ovarian Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EV-PURE in Premature Ovarian Failure Drug Details: EV-PURE is under development...
-
Analyst Opinions
Africa Energy Transition Market Trends and Analysis by Sectors and Companies Driving Development
Africa Energy Transition Market Report Overview Africa is set to experience significant social, economic, and environmental changes that will heavily influence the region’s energy demand in the coming years. The power market in Africa still heavily relies on a combination of thermal power and large-scale hydropower projects to meet its power demand. However, the region’s energy transition is gaining pace as countries increasingly capitalize on the falling cost of producing renewable energy and the region’s rich renewable resources, which is...
-
Product Insights
NewTauopathies – Drugs In Development, 2024
Empower your strategies with our Tauopathies – Drugs In Development, 2024 report and make more profitable business decisions. Tauopathies are a group of neurodegenerative disorders characterized by the aggregation of tau protein into neurofibrillary or gliofibrillary tangles in the human brain. Tau protein normally stabilizes microtubules, which are essential for intracellular transport and communication. However, when tau becomes hyperphosphorylated or misfolded, it dissociates from microtubules and forms insoluble aggregates that impair neuronal function and survival. Tauopathies can present with various clinical...
-
Product Insights
NewGraft Versus Host Disease (GVHD) – Drugs In Development, 2024
Empower your strategies with our Graft Versus Host Disease (GVHD) – Drugs In Development, 2024 report and make more profitable business decisions. Graft-versus-host disease (GVHD) is a complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted donor cells attack the transplant recipient's body. Symptoms include abdominal pain or cramps; nausea, vomiting, and diarrhea; dry or irritated eyes; jaundice; shortness of breath; vaginal dryness; and weight loss. Treatment includes immunosuppressants. The Graft Versus Host...
-
Product Insights
NewBone Marrow Transplant Rejection – Drugs In Development, 2024
Empower your strategies with our Bone Marrow Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Bone marrow transplant rejection is a complication that can occur after a stem cell or bone marrow transplant. The newly transplanted donor cells attack the transplant recipient's body. Symptoms include chest pain, chills, drop in blood pressure, fever, flushing, funny taste in the mouth, headache, hives, nausea, pain, and shortness of breath. Treatment includes immunosuppressive drugs. The Bone Marrow Transplant...